# Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach

> **NCT01640782** · PHASE3 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 1100 (actual)

## Conditions studied

- Adenocarcinoma of the Stomach
- Adenocarcinoma of the Gastroesophageal Junction

## Interventions

- **DRUG:** Irinotecan, Leucovorin, 5-Fluorouracil, Docetaxel, Cisplatin
- **DRUG:** Leucovorin, 5-Fluorouracil

## Key facts

- **NCT ID:** NCT01640782
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2014-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01640782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01640782, "Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01640782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*